Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NASDAQ:AVGO NYSE:PG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsAVGOBroadcom$384.05-4.0%$404.62$269.58▼$495.00$1.90T1.4526.15 million shs21.23 million shsPGProcter & Gamble$148.41+0.9%$146.60$137.62▼$167.25$342.40B0.399.28 million shs7.78 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%AVGOBroadcom-3.98%+2.71%+0.52%+0.93%+39.97%PGProcter & Gamble+0.86%-0.64%-0.70%+2.79%-5.44%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsAVGOBroadcom$384.05-4.0%$404.62$269.58▼$495.00$1.90T1.4526.15 million shs21.23 million shsPGProcter & Gamble$148.41+0.9%$146.60$137.62▼$167.25$342.40B0.399.28 million shs7.78 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%AVGOBroadcom-3.98%+2.71%+0.52%+0.93%+39.97%PGProcter & Gamble+0.86%-0.64%-0.70%+2.79%-5.44%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.84Moderate Buy$266.247.33% UpsideAVGOBroadcom 2.91Moderate Buy$493.2428.43% UpsidePGProcter & Gamble 2.57Moderate Buy$161.428.76% UpsideCurrent Analyst Ratings BreakdownLatest AVGO, PG, and ABBV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026ABBVAbbVie UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$230.00 ➝ $260.007/13/2026ABBVAbbVie BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$258.00 ➝ $300.007/10/2026ABBVAbbVie Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $295.007/10/2026ABBVAbbVie Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$234.00 ➝ $276.007/10/2026ABBVAbbVie Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$260.00 ➝ $280.007/10/2026PGProcter & Gamble Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$170.00 ➝ $166.007/9/2026ABBVAbbVie GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$249.00 ➝ $261.007/9/2026ABBVAbbVie JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $280.007/7/2026AVGOBroadcom Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold7/6/2026ABBVAbbVie HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$300.007/6/2026ABBVAbbVie Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$240.00 ➝ $265.00(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B7.17$15.14 per share16.38($1.83) per share-135.55AVGOBroadcom$63.89B28.60$7.40 per share51.92$17.15 per share22.39PGProcter & Gamble$84.28B4.10$8.45 per share17.57$21.97 per share6.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03122.2015.470.815.79%-576.45%13.39%7/31/2026 (Estimated)AVGOBroadcom$23.13B$6.0064.0121.780.7038.85%41.61%19.55%9/3/2026 (Estimated)PGProcter & Gamble$15.97B$6.8421.7021.056.2619.16%32.00%13.27%7/29/2026 (Estimated)Latest AVGO, PG, and ABBV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/31/2026Q2 2026ABBVAbbVie$3.71N/AN/AN/A$16.78 billionN/A7/29/2026Q4 2026PGProcter & Gamble$1.42N/AN/AN/A$21.43 billionN/A6/3/2026Q2 2026AVGOBroadcom$2.40$2.44+$0.04$1.91$22.13 billion$22.19 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/24/2026Q3 2026PGProcter & Gamble$1.56$1.59+$0.03$1.63$21.52 billion$21.24 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.922.79%+6.80%340.89%53 YearsAVGOBroadcom$2.600.68%+12.67%43.33%15 YearsPGProcter & Gamble$4.352.93%+6.13%63.60%70 YearsLatest AVGO, PG, and ABBV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2026ABBVAbbViequarterly$1.733.19%7/15/20267/15/20268/14/20266/2/2026AVGOBroadcomquarterly$0.650.66%6/22/20266/22/20266/30/20264/14/2026PGProcter & Gamblequarterly$1.08852.94%4/24/20264/24/20265/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68AVGOBroadcom0.712.242.01PGProcter & Gamble0.440.730.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%AVGOBroadcom76.43%PGProcter & Gamble65.77%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%AVGOBroadcom1.90%PGProcter & Gamble0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableAVGOBroadcom33,0004.76 billion4.67 billionOptionablePGProcter & Gamble109,0002.33 billion2.32 billionOptionableAVGO, PG, and ABBV HeadlinesRecent News About These CompaniesAMG National Trust Bank Purchases 8,519 Shares of Procter & Gamble Company (The) $PG59 minutes ago | marketbeat.comIs CLX A Value Trap? The Evidence Leans That WayJuly 13 at 10:46 PM | trefis.comTInvestors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to KnowJuly 13 at 12:45 PM | finance.yahoo.comInvestors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to KnowJuly 13 at 10:01 AM | zacks.comNavigate Wealth Management LLC Invests $1.85 Million in Procter & Gamble Company (The) $PGJuly 13 at 5:43 AM | marketbeat.comCORDA Investment Management LLC. Boosts Stake in Procter & Gamble Company (The) $PGJuly 13 at 4:07 AM | marketbeat.comProcter & Gamble Company (The) $PG Stock Holdings Raised by Diversify Wealth Management LLCJuly 13 at 3:59 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Purchased by Arbejdsmarkedets TillaegspensionJuly 13 at 3:19 AM | marketbeat.comProcter & Gamble (PG) Plans 7,000 Job Cuts To Help Offset Tariff CostsJuly 12 at 9:38 PM | finance.yahoo.comLGT Fund Management Co Ltd. Raises Holdings in Procter & Gamble Company (The) $PGJuly 12 at 1:44 PM | marketbeat.comInternational Assets Investment Management LLC Has $2.64 Million Stock Holdings in Procter & Gamble Company (The) $PGJuly 12 at 1:44 PM | marketbeat.comMidwest Trust Co Purchases 33,608 Shares of Procter & Gamble Company (The) $PGJuly 12 at 1:11 PM | marketbeat.comProcter & Gamble vs PepsiCo: The Better Stock For Passive Income InvestorsJuly 12 at 1:00 PM | 247wallst.comFerguson Wellman Capital Management Inc. Boosts Holdings in Procter & Gamble Company (The) $PGJuly 12 at 11:27 AM | marketbeat.comCullinan Associates Inc. Has $32.60 Million Holdings in Procter & Gamble Company (The) $PGJuly 12 at 11:19 AM | marketbeat.comFifth Third Bancorp Grows Position in Procter & Gamble Company (The) $PGJuly 12 at 11:12 AM | marketbeat.comProcter & Gamble Company (The) $PG Stock Holdings Lifted by ARQ Wealth Advisors LLCJuly 12 at 10:33 AM | marketbeat.comVolatility Isn’t the Risk You Should Fear — These AreJuly 11 at 12:47 PM | 247wallst.comAnalysts’ Opinions Are Mixed on These Consumer Goods Stocks: Procter & Gamble (PG) and PepsiCo (PEP)July 11 at 12:47 PM | theglobeandmail.comProcter & Gamble (NYSE:PG) Value Gap Draws Fresh AttentionJuly 11 at 12:47 PM | kalkinemedia.comKCandriam S.C.A. Increases Position in Procter & Gamble Company (The) $PGJuly 11 at 9:19 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese AI Stocks Have Insider Selling, But Buyers Still Have a Reason to StayBy Thomas Hughes | June 23, 2026JPMorgan Stands by Sky-High Broadcom Target as Shares SlideBy Leo Miller | June 29, 2026VMware: Broadcom's Second Biggest Business Set to AccelerateBy Leo Miller | June 19, 2026Frozen Assets: How Super Micro Puts AI Heat on IceBy Jeffrey Neal Johnson | June 24, 2026The AI Chip Sell-Off Looks Scary, But the Real Story May Be LiquidityBy Jeffrey Neal Johnson | July 7, 2026AVGO, PG, and ABBV Company DescriptionsAbbVie NYSE:ABBV$248.06 -0.02 (-0.01%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$248.26 +0.19 (+0.08%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Broadcom NASDAQ:AVGO$384.05 -15.92 (-3.98%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$389.00 +4.95 (+1.29%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.Procter & Gamble NYSE:PG$148.41 +1.37 (+0.93%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$147.86 -0.55 (-0.37%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
